Holen Sie sich die Stockscreener-App
61.97
3.16%
-2.02
Vorhandelsmarkt:
60.50
-1.47
-2.37%
Finanzdaten der Crispr Therapeutics Ag-Aktie (CRSP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.12%
0.892
|
0.865 | 35.69 | 0.602 | 0.517 |
Operating Expenses
|
54.21%
230.22
|
149.29 | 100.28 | 110.73 | 151.78 |
| Benefits Costs and Expenses |
53.33%
208.15
|
135.75 | 72.30 | 85.67 | 125.64 |
| Costs And Expenses |
53.33%
208.15
|
135.75 | 72.30 | 85.67 | 125.64 |
| Operating Income/Loss |
54.51%
-229.32
|
-148.42 | -64.59 | -110.13 | -151.26 |
| Nonoperating Income/Loss |
63.01%
22.07
|
13.54 | 27.98 | 25.06 | 26.14 |
| Income/Loss From Continuing Operations Before Tax |
53.65%
-207.26
|
-134.89 | -36.61 | -85.07 | -125.12 |
| Income Tax Expense/Benefit |
16.50%
1.292
|
1.109 | 0.70 | 0.876 | 1.287 |
| Income/Loss From Continuing Operations After Tax |
53.35%
-208.55
|
-136.00 | -37.31 | -85.94 | -126.41 |
|
Net Income/Loss
|
53.35%
-208.55
|
-136.00 | -37.31 | -85.94 | -126.41 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.32%
87.07
|
85.94 | 0.3711 | 85.23 | 84.92 |
| Diluted Average Shares |
1.32%
87.07
|
85.94 | 0.3711 | 85.23 | 84.92 |
| Basic Earnings Per Share |
51.90%
-2.40
|
-1.58 | -0.42 | -1.01 | -1.49 |
| Diluted Earnings Per Share |
51.90%
-2.40
|
-1.58 | -0.42 | -1.01 | -1.49 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):